Macro Finance
Roivant Expects FDA to Approve First Major Drug
Bloomberg Markets·August 6, 2026·1 min read
Roivant Chief Executive Officer Matt Gline expects the FDA to approve the launch of a drug used to fight a debilitating skin disease. He says the drug should be on the market by September. He spoke on "Bloomberg Open Interest."
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.